James Laughlin explains that testosterone replacement therapy, when properly monitored and dosed to normal ranges, doesn't increase cancer risk and may lower it. Most age-management doctors aim to restore testosterone to the upper end of normal, not the extreme levels bodybuilders use.
The data is quite clear that if done correctly and it's tracked and monitored, it does not increase your risks of prostate or colon cancer. In fact, there's risk reduction. Who doesn't get cancer? Young, healthy men with normal testosterone levels. Now, we're not talking about, you know, bodybuilder level. We're talking about a healthy correction to upper limits of normal. That's what most age management practitioners would recommend, and that's what the data support.
